Tag: carcinogenic drug

Brown-Forman and The Coca-Cola Company have expanded their Jack Daniel’s & Coca-Cola ready-to-drink (RTD) portfolio with new 16 oz single-serve cans. The new format, available now across the U.S. for both the classic and Zero Sugar expressions, features a 5% ABV designed for convenience and portability.

The launch taps into the continued growth of the RTD category, which, according to DISCUS, grew by 16.4% in 2025. This new, larger format offers a lower ABV compared to the 7% ABV found in the brand’s original 12 oz cans, positioning it as a more sessionable option.

The companies said the 16 oz can is built for convenience-driven occasions and aims to capture “on-the-fly” purchases in retail and on-premise channels.

Mary Beth O’Mara, Jack Daniel’s RTD Brand Director, said: “Single-serve continues to grow in the ready-to-drink category and this size gives our retail, convenience, and on-premise partners an easy way to capture on-the-fly purchases while offering a lighter, more sessionable Jack & Coke.”